FDA Inspection
Aurolife Pharma, LLCAurolife Pharma, LLC – FDA Inspection, May 25, 2011
Record Details
This FDA Inspection record concerns Aurolife Pharma, LLC, with an inspection on May 25, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Aurolife Pharma, LLC
- Inspection Date
- May 25, 2011
- Product Type
- Drugs
View Company Profile
ID · df9386a6-7efe-4aac-acde-70fa19ee80b2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 727943
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Aurolife Pharma, LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| December 7, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 28, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 12, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aurolife Pharma, LLC
- FDA Inspection 1158258 - 2021-12-07
- FDA Inspection 1109452 - 2019-10-22
- FDA Inspection 1055912 - 2018-06-14
- FDA Inspection 980107 - 2016-07-28
- FDA Inspection 952634 - 2016-01-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.